Drug Database
Back to search

Finland· FI-REL-REL1197

Ipsatol

A biperiden product containing biperiden hydrochloride, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC N04AA02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedIpsatolATCN04AA02REGISTER NO.FI-REL-REL1197PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about biperiden hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Biperiden is registered in 15 of 19 countries.

Countries holding a registration under ATC N04AA02 (biperiden), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 9 of them publish a price we can compare per daily dose
Search biperiden products by name

Biperiden · ATC N04AA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of biperiden costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.28 in France to $1.58 in Switzerland — a ×5.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Biperiden · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.58
  • IT Italy$0.36
  • FR France$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Biperiden hydrochloride
Manufacturer
Orion Corporation Orion Pharma
Country
Finland (FI)
ATC code
N04AA02
ATC class
Biperiden
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for biperiden.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check biperiden against other medicinesHow interaction checks work

Biperiden · interactions on record

89 records

  • 3 severe
  • 85 moderate
  • 1 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Biperiden in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All biperiden products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Akineton
  • Belgium · Akineton
  • Bulgaria · Акинестат, Акинетон
  • Cyprus · Akineton Retard
  • Czechia · Akineton
  • Germany · Akineton, Biperiden Neuraxpharm
  • Denmark · Akineton
  • Spain · Akinetón, Akinetón Retard
  • France · Akineton L.P.
  • Greece · Akineton
  • Croatia · Akineton, Mendilex
  • Hungary · Akineton
  • Ireland · Akineton, Akineton Retard
  • Iceland · Akineton
  • Italy · Akineton
  • Luxembourg · Akineton
  • Netherlands · Akineton
  • Norway · Akineton
  • Poland · Akineton, Akineton Sr
  • Portugal · Akineton, Akineton Retard
  • Sweden · Akineton
  • Slovenia · Akineton
  • Slovakia · Akineton, Akineton Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/244751e3-23e5-4569-a507-cff12445e254
GET /v1/drugs/244751e3-23e5-4569-a507-cff12445e254?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "10",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "mg",
  "strength": "2 mg",
  "atc_label": "biperideeni",
  "ma_number": "7542",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1197",
  "authorised_at": "1978-01-25"
}
API referenceMCP serverPlans

See everything about biperiden.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console